The Chosun Ilbo on MSN
GC Biopharma advances mRNA tech for domestic, global markets
GC Biopharma is accelerating the acquisition of next-generation biotechnology to develop not only COVID-19 vaccines but also ...
Hyderabad startup PopVax develops personalised cancer vaccines using AI, machine learning, and mRNA tech to target unique tumour mutations.
U.S. research cuts and vaccine skepticism have delivered Europe an opportunity to establish itself as a leader in science — ...
5don MSN
Will Moderna Soar on Nov. 6?
Moderna shares have outperformed tech giants this year.
A personalized melanoma vaccine could prevent recurrence and fuel Merck’s growth.
AstraZeneca signals plans to explore mRNA cancer vaccines, weighing personalized and non-personalized approaches as R&D ...
Takara Bio signs final agreement with S-RACMO for transfer of cell processing contract businessTakara Bio announced on November 2 that it has signed a final agreement with S-RACMO (Suita City, Osaka ...
Merck and Moderna’s new personalized cancer vaccine paired with the standard of care reduced the risk of recurrence and death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results